SCHEMBL20924813

SCHEMBL20924813

O=NCC(=O)Nc1ccncn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
EPHX2 P34913 1/20 0.43
GAA P10253 1/20 0.42
P2RX7 Q99572 1/20 0.41
NLRP3 Q96P20 3/20 0.40
FAAH O00519 2/20 0.38
ATR Q13535 1/20 0.38
NAMPT P43490 1/20 0.38
MKNK1 Q9BUB5 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRL1 P41146 1/20 0.35
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2685376 0.83 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL14920768 0.81 CHRNB2 (0.51) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL4466182 0.79 P2RX7 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL6361625 0.79 SMN1; SMN2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL1433052 0.79 P2RX7 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL19308440 0.78 TDP1 (0.55) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL19177369 0.77 RAB9A (0.49) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL19116526 0.75 SMN1; SMN2 (0.57) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL19169610 0.75 ADORA1 (0.45) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2
SCHEMBL5264810 0.74 CHRNB2 (0.55) CHRNB2CHRNB4CHRNA3CHRNA4EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788326-B1 N-(PYRID-4-YL)AMIDES AND N-(PYRIMIDIN-4-YL)AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC USE GALDERMA RES & DEV (FR) 2019-04-24 EP disclosed